BROYDRICK & ASSOCIATES

Lobbying for TONIX PHARMACEUTICALS · Pharmaceutical development and manufacturing.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · New York · House · Senate · $20,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Pharmacy

Funding new drug for PTSD and COVID 19, BARDA appropriations.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem